Stock Events

Stock Events

Aligos Therapeutics (ALGS) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-13.08

-8.47

-3.86

0.75

Details

Expected EPS

-2.9775

Actual EPS

-2.11

Surprise EPS

0.87

Surprise Percent

+29.14%

Description

Aligos Therapeutics (ALGS) has reported earnings of -2.11 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.